By Shotsy
Report updated May 19, 2026
Shotsy GLP-1 Tracker
For individuals prescribed GLP-1 receptor agonists for weight management or type 2 diabetes requiring precise dose tracking.
Shotsy GLP-1 Tracker is a well-regarded health & fitness app that is available. With a 4.8/5 rating from 23.2K reviews, it maintains solid user satisfaction. Users particularly appreciate estimated medication level charts provide actionable insights for managing injection schedules and symptoms, though paywalling previously free features like medication level charts creates friction for long-term users remains a common concern.
What is Shotsy GLP-1 Tracker?
Shotsy is a specialized medication tracker for GLP-1 weight loss and diabetes patients, providing dose scheduling and clinical-data visualizations on iOS.
Users hire Shotsy to manage the complexity of multi-drug injection schedules and visualize medication levels, which standard calorie trackers fail to address.
Current Momentum
v3.0 · 6d ago
Active- Shipped chart interaction and logging fixes.
- Transitioned core features to subscription model.
Active Nemesis
Lose It! – Calorie Counter
By FitNow
Other Rivals
7-Day Rank Pulse 🇺🇸
Health & FitnessNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Visualizes medication concentration over time using peer-reviewed clinical data.
Supports simultaneous tracking of multiple GLP-1 injections and daily oral pills.
Automates data import for weight, calories, protein, and water intake.
How much does it cost?
- Free access to basic logging
- Subscription for advanced analytics and medication levels
Transitioning from a free tool to a subscription model has created significant friction with long-term users.
Who Built It?
Empowering GLP-1 medication users with data-driven tracking and clinical visualization tools to manage their weight-loss journey.
Portfolio
2
Apps
Who is Shotsy?
Shotsy has established a first-mover advantage in the GLP-1 companion app space by focusing on a specific technical moat: visualizing estimated drug concentration levels based on clinical data. Unlike generic weight-loss trackers, the product targets the unique physiological tracking needs of semaglutide and tirzepatide users. The current trajectory shows an aggressive iteration cycle, likely aimed at securing the dominant utility position before pharmaceutical incumbents or larger health platforms integrate similar features.
Who is Shotsy for?
- Individuals using GLP-1 receptor agonists for weight management or Type 2 Diabetes who prioritize data-driven insights
- Privacy
Portfolio momentum
Released 12 updates for their single active title in the last 6 months, indicating an intense development and iteration cycle.
What other apps does Shotsy make?
Shotsy - GLP-1 Tracker
What do users think recently?
High confidence · Latest 84 of 98 total reviews analyzed · Based on 98 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a excited sentiment. Users appreciate estimated medication level charts provide actionable insights for managing injection schedules and symptoms, but report paywalling previously free features like medication level charts creates friction for long-term users.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for Shotsy GLP-1 Tracker?
How's The Health & Fitness Market?
How does it evolve in the Health & Fitness market?
Shotsy holds a #80 Grossing rank in the US Health & Fitness category, with international growth evidenced by a #25 Grossing rank in Uruguay. The gap between its utility-driven retention and the recent subscription-gate friction suggests a need to re-align monetization with user value.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇧🇭 Bahrain | Health & Fitness | iOSGrossing | #50 | NEW |
| 🇺🇸 US | Health & Fitness | iOSGrossing | #79 |
The rivals identified
The Nemesis
- -
Weaker sentiment at 35/100 — but still a direct threat
- -
Extensive food database with barcode scanning capabilities that Shotsy currently lacks for nutrition tracking.
- -
Advanced community features and social challenges that drive long-term user retention beyond simple logging.
Contenders
Integrates psychological coaching and daily curriculum modules to address the root causes of weight gain.
Color-coded food density system provides actionable dietary guidance that goes beyond basic calorie counting.
Calorie Counter - MyNetDiary
★4.8 (146.6K)MyNetDiary Inc.
⚡Strong clinical focus and high update frequency position it as a reliable alternative for medical-grade tracking.
Includes specialized tracking modules for diabetes and pre-diabetes management, directly overlapping with GLP-1 user needs.
High-frequency release cadence ensures rapid integration of new health data standards and user-requested features.
Peers
Deep integration of macro-nutrient tracking specifically optimized for ketogenic and low-carb dietary protocols.
Robust recipe database and meal planning tools that provide more utility than simple dose logging.
Uses heart rate variability (HRV) data to provide actionable insights on recovery and overall health status.
Aggregates data from multiple wearables to create a comprehensive health dashboard beyond manual logging.
Fullscript
★4.9 (100.5K)HealthWave Inc.
⚡Professional-grade supplement and medication management platform that serves the clinical side of the GLP-1 journey.
Direct integration with healthcare providers for prescription management and professional supplement recommendations.
Focuses on the clinical supply chain rather than the consumer-facing weight loss tracking experience.
Fitbod: Gym & Fitness Planner
★4.8 (267.9K)Fitbod Inc.
⚡Focuses on the physical activity component of weight loss, serving as a complementary tool for GLP-1 users.
AI-driven workout generation that adapts to available equipment and user recovery levels in real-time.
Visualizes muscle recovery and strength progression, providing a different value proposition than medication tracking.
New Kids on the Block
AI Calorie Counter - Appediet
★4.7 (59.2K)Appediet Information PTE. LTD
⚡Aggressive release schedule and AI-first positioning indicate a rapid attempt to capture the automated logging market.
Leverages AI image recognition to automate food logging, significantly reducing the friction of manual entry.
Rapid deployment of feature updates suggests a high-velocity testing strategy to find product-market fit.
The outtake for Shotsy GLP-1 Tracker
Strengths to defend, gaps to attack
Core Strengths
- Clinical-data visualization creates high switching costs
- Multi-medication scheduling addresses complex poly-pharmacy needs
Critical Frictions
- Subscription gate for core features drives churn
- Data loss incidents post-update erode user trust
Growth Levers
- Integration of milestone photo tracking for progress
- Expansion into non-GLP-1 chronic medication tracking
Market Threats
- AI-first competitors reducing manual logging friction
- Subscription-model backlash increasing churn to free alternatives
What are the next best moves?
Audit data persistence logic because data loss is a top-3 complaint → restore user trust
Data loss incidents are eroding trust in medical history records.
Trade-off: Pause the new photo-milestone feature sprint — data reliability is a higher retention priority.
Re-tier subscription gates because paywalling core charts is the #1 complaint → reduce churn
Users perceive the current subscription price as high for features they could replicate manually.
Trade-off: Delay the non-GLP-1 medication support rollout — fixing the core monetization funnel is critical.
A counter-intuitive read
The subscription-gate backlash is not a pricing problem but a value-perception failure: users feel the app is a utility, not a service, and the current paywall ignores that distinction.
Feature Gaps vs Competitors
- Barcode scanning (available in Lose It! but missing here)
- Psychological coaching (available in Noom but missing here)
Key Takeaways
Shotsy holds a strong category lead through specialized clinical-data visualization, but the recent subscription-gate friction and data-loss incidents threaten long-term retention, so the PM must prioritize data reliability and re-tier the monetization model to prevent churn to free alternatives.
Where Is It Heading?
Mixed Signals
The GLP-1 tracking market is consolidating, with generalist apps adding specialized modules to compete with niche tools like Shotsy. The app's future depends on whether it can maintain its clinical-data moat while resolving the technical instability that currently undermines its premium positioning.
Data loss incidents following the latest update erode trust, which directly increases churn risk for long-term users.
High international grossing ranks in emerging markets suggest strong demand for the specialized medication-level visualization feature.